Connect with us

Technology

Vaccines Won’t Protect Millions of Patients With Weakened Immune Systems – The New York Times

Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.

Published

on

Article feature image
ADVERTISEMENT

In a follow-up, the scientists found that 34 percent of people taking the drug were protected after a single dose of the Pfizer vaccine and only 27 percent after a single dose of the AstraZeneca vaccine. (In Britain, the current practice is to delay second doses to stretch vaccine availability.)
Likewise, another study published last month indicated that fewer than 15 percent of patients with cancers of blood or the immune system, and fewer than 40 percent of those with solid tumors, produced antibodies…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Google I/O 2021: the biggest announcements – The Verge
Article feature image
Shopify stock pops after Google announces online shopping expansion – CNBC
Article feature image
Google’s Project Starline Videoconference Tech Wants to Turn You Into a Hologram – WIRED